HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Marra Selected Research

voacamine

3/2007Autophagy-mediated chemosensitizing effect of the plant alkaloid voacamine on multidrug resistant cells.
12/2005Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells.
12/2003Voacamine, a bisindolic alkaloid from Peschiera fuchsiaefolia, enhances the cytotoxic effect of doxorubicin on multidrug-resistant tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Marra Research Topics

Disease

28Neoplasms (Cancer)
12/2016 - 01/2001
5Carcinoma (Carcinomatosis)
06/2017 - 08/2002
3Type 2 Diabetes Mellitus (MODY)
01/2010 - 04/2001
3Melanoma (Melanoma, Malignant)
07/2004 - 04/2002
2Periodontitis
09/2020 - 09/2020
2Colorectal Neoplasms (Colorectal Cancer)
12/2016 - 04/2012
2Adenocarcinoma
12/2016 - 04/2011
2Colonic Neoplasms (Colon Cancer)
04/2012 - 06/2004
2Coronary Disease (Coronary Heart Disease)
07/2011 - 04/2001
2Hepatocellular Carcinoma (Hepatoma)
04/2011 - 07/2009
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2010 - 10/2007
2Insulin Resistance
10/2007 - 03/2006
2Osteosarcoma (Osteogenic Sarcoma)
03/2007 - 12/2005
1Hemorrhage
09/2020
1Peri-Implantitis
09/2020
1Calculi (Calculus)
09/2020
1Periodontal Pocket (Periodontal Pockets)
09/2020
1Periodontal Diseases (Periodontal Disease)
09/2020
1Gingival Recession
09/2020
1Glycogen Storage Disease Type VI (Glycogenosis Type VI)
06/2017
1Pleomorphic Adenoma
06/2017
1Primary Myelofibrosis (Myelosclerosis)
01/2017
1Splenomegaly
01/2017
1Cholangiocarcinoma
12/2016
1Pain (Aches)
07/2011
1Cardiotoxicity
07/2011
1Pancreatic Neoplasms (Pancreatic Cancer)
04/2011
1Prostatic Neoplasms (Prostate Cancer)
01/2011
1Chronic Kidney Failure (Chronic Renal Failure)
01/2010
1Myocardial Infarction
01/2010
1Bone Diseases (Bone Disease)
11/2009
1Fibrosis (Cirrhosis)
07/2009
1Infections
07/2009

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2013 - 07/2004
7Pharmaceutical PreparationsIBA
04/2012 - 04/2002
7Interferon-alpha (Interferon Alfa)IBA
12/2008 - 02/2003
6Epidermal Growth Factor (EGF)IBA
08/2009 - 02/2003
5Doxorubicin (Adriamycin)FDA LinkGeneric
06/2017 - 04/2002
5PolyaminesIBA
12/2008 - 06/2004
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2005 - 04/2002
3ErbB Receptors (EGF Receptor)IBA
12/2016 - 08/2009
3Protein Isoforms (Isoforms)IBA
01/2013 - 09/2001
3Peptide Elongation Factors (Elongation Factor)IBA
03/2012 - 07/2004
3CytokinesIBA
08/2009 - 07/2004
3Docetaxel (Taxotere)FDA Link
12/2008 - 09/2005
3Interleukin-6 (Interleukin 6)IBA
10/2007 - 08/2001
3AlkaloidsIBA
03/2007 - 12/2003
3voacamineIBA
03/2007 - 12/2003
21-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2020 - 09/2020
2GemcitabineFDA Link
04/2012 - 04/2011
2Reactive Oxygen Species (Oxygen Radicals)IBA
04/2011 - 05/2008
2Sorafenib (BAY 43-9006)FDA Link
04/2011 - 06/2006
2tipifarnib (R115777)IBA
08/2009 - 09/2005
2TransferasesIBA
08/2009 - 09/2005
2Adenylyl Cyclases (Adenylyl Cyclase)IBA
08/2009 - 02/2007
2InterferonsIBA
08/2009 - 07/2009
2AminesIBA
12/2008 - 06/2004
2Oxidoreductases (Dehydrogenase)IBA
12/2008 - 06/2004
2SpermineIBA
08/2007 - 06/2004
2EnzymesIBA
08/2007 - 07/2004
2Peptide Initiation Factors (Initiation Factor)IBA
07/2004 - 06/2003
2Eukaryotic Translation Initiation Factor 5AIBA
06/2003 - 01/2001
1Dental Implants (Dental Implant)IBA
09/2020
1Methylene Blue (Methylthioninium Chloride)FDA Link
09/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2017
1Cisplatin (Platino)FDA LinkGeneric
06/2017
1Janus Kinase InhibitorsIBA
01/2017
1Thrombopoietin (c-mpl Ligand)IBA
01/2017
1ruxolitinibIBA
01/2017
1Bevacizumab (Avastin)FDA Link
12/2016
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2016
1AntigensIBA
04/2012
1Immunoglobulin G (IgG)IBA
04/2012
1Neoplasm Antigens (Tumor Antigens)IBA
04/2012
1Irinotecan (Camptosar)FDA LinkGeneric
04/2012
1Cetuximab (Erbitux)FDA Link
04/2012
1Monoclonal AntibodiesIBA
04/2012
1AnthracyclinesIBA
07/2011
1Fluorouracil (Carac)FDA LinkGeneric
07/2011
1CannabinoidsIBA
04/2011
1Octreotide (Sandostatin)FDA LinkGeneric
04/2011
1SolutionsIBA
01/2011
1Diphosphonates (Bisphosphonates)IBA
01/2011
1Antineoplastic Agents (Antineoplastics)IBA
01/2011
1NitrogenIBA
01/2010
1Interleukin-10 (Interleukin 10)IBA
01/2010
1Urea (Carbamide)FDA LinkGeneric
01/2010
1Zoledronic Acid (Zometa)FDA Link
11/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2009
1Tyrosine Kinase InhibitorsIBA
08/2009
1Gefitinib (Iressa)FDA Link
08/2009
1Transaminases (Aminotransferases)IBA
07/2009
1Alanine (L-Alanine)FDA Link
07/2009
1Antiviral Agents (Antivirals)IBA
07/2009

Therapy/Procedure

8Therapeutics
06/2017 - 12/2003
5Drug Therapy (Chemotherapy)
04/2012 - 12/2003
2Photochemotherapy (Photodynamic Therapy)
09/2020 - 09/2020
2Aftercare (After-Treatment)
09/2020 - 04/2012
1Lasers (Laser)
09/2020
1Contraindications
07/2009